MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition:   Solid Tumor, Adult Intervention:   Drug: Vaccine Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials